nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—SIGMAR1—amyotrophic lateral sclerosis	0.533	1	CbGaD
Progesterone—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.193	0.691	CbGbCtD
Progesterone—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.086	0.309	CbGbCtD
Progesterone—Uterine leiomyoma—Riluzole—amyotrophic lateral sclerosis	0.00445	0.0401	CcSEcCtD
Progesterone—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0242	CcSEcCtD
Progesterone—SHBG—hindlimb—amyotrophic lateral sclerosis	0.00229	0.0774	CbGeAlD
Progesterone—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0191	CcSEcCtD
Progesterone—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0163	CcSEcCtD
Progesterone—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0161	CcSEcCtD
Progesterone—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0153	CcSEcCtD
Progesterone—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0152	CcSEcCtD
Progesterone—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0149	CcSEcCtD
Progesterone—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0148	CcSEcCtD
Progesterone—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.0146	CcSEcCtD
Progesterone—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00156	0.014	CcSEcCtD
Progesterone—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00156	0.014	CcSEcCtD
Progesterone—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0132	CcSEcCtD
Progesterone—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0127	CcSEcCtD
Progesterone—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0126	CcSEcCtD
Progesterone—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00133	0.012	CcSEcCtD
Progesterone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0119	CcSEcCtD
Progesterone—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0118	CcSEcCtD
Progesterone—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0113	CcSEcCtD
Progesterone—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0111	CcSEcCtD
Progesterone—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0107	CcSEcCtD
Progesterone—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0105	CcSEcCtD
Progesterone—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0105	CcSEcCtD
Progesterone—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0101	CcSEcCtD
Progesterone—SLC22A3—tongue—amyotrophic lateral sclerosis	0.00112	0.0379	CbGeAlD
Progesterone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00993	CcSEcCtD
Progesterone—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00961	CcSEcCtD
Progesterone—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00945	CcSEcCtD
Progesterone—SHBG—hindbrain—amyotrophic lateral sclerosis	0.00104	0.0352	CbGeAlD
Progesterone—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00917	CcSEcCtD
Progesterone—NR3C2—hindbrain—amyotrophic lateral sclerosis	0.00101	0.0342	CbGeAlD
Progesterone—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00907	CcSEcCtD
Progesterone—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.000988	0.0089	CcSEcCtD
Progesterone—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000988	0.0089	CcSEcCtD
Progesterone—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.000965	0.00869	CcSEcCtD
Progesterone—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.000942	0.00849	CcSEcCtD
Progesterone—PGR—hindbrain—amyotrophic lateral sclerosis	0.000939	0.0317	CbGeAlD
Progesterone—Injury—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00826	CcSEcCtD
Progesterone—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000909	0.00819	CcSEcCtD
Progesterone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00808	CcSEcCtD
Progesterone—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000886	0.00798	CcSEcCtD
Progesterone—Purpura—Riluzole—amyotrophic lateral sclerosis	0.000875	0.00788	CcSEcCtD
Progesterone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.000871	0.00784	CcSEcCtD
Progesterone—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000867	0.00781	CcSEcCtD
Progesterone—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000843	0.00759	CcSEcCtD
Progesterone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000843	0.00759	CcSEcCtD
Progesterone—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.000836	0.00753	CcSEcCtD
Progesterone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00083	0.00747	CcSEcCtD
Progesterone—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00083	0.00747	CcSEcCtD
Progesterone—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000814	0.00733	CcSEcCtD
Progesterone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000799	0.00719	CcSEcCtD
Progesterone—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000778	0.00701	CcSEcCtD
Progesterone—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.000762	0.00686	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000759	0.00684	CcSEcCtD
Progesterone—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000746	0.00672	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000743	0.0067	CcSEcCtD
Progesterone—ESR1—hindbrain—amyotrophic lateral sclerosis	0.000734	0.0248	CbGeAlD
Progesterone—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000733	0.00661	CcSEcCtD
Progesterone—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000729	0.00656	CcSEcCtD
Progesterone—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000729	0.00656	CcSEcCtD
Progesterone—NR3C1—nerve—amyotrophic lateral sclerosis	0.000723	0.0245	CbGeAlD
Progesterone—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00071	0.00639	CcSEcCtD
Progesterone—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000701	0.00631	CcSEcCtD
Progesterone—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000698	0.00629	CcSEcCtD
Progesterone—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000681	0.00614	CcSEcCtD
Progesterone—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000673	0.00606	CcSEcCtD
Progesterone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000663	0.00597	CcSEcCtD
Progesterone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000659	0.00594	CcSEcCtD
Progesterone—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000653	0.00588	CcSEcCtD
Progesterone—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00585	CcSEcCtD
Progesterone—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00585	CcSEcCtD
Progesterone—Depression—Riluzole—amyotrophic lateral sclerosis	0.000648	0.00583	CcSEcCtD
Progesterone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000637	0.00573	CcSEcCtD
Progesterone—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000633	0.0057	CcSEcCtD
Progesterone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000631	0.00569	CcSEcCtD
Progesterone—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000614	0.00553	CcSEcCtD
Progesterone—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000609	0.00549	CcSEcCtD
Progesterone—SHBG—brainstem—amyotrophic lateral sclerosis	0.000597	0.0202	CbGeAlD
Progesterone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000586	0.00528	CcSEcCtD
Progesterone—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00526	CcSEcCtD
Progesterone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000583	0.00525	CcSEcCtD
Progesterone—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000583	0.00525	CcSEcCtD
Progesterone—NR3C2—brainstem—amyotrophic lateral sclerosis	0.000579	0.0196	CbGeAlD
Progesterone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000579	0.00521	CcSEcCtD
Progesterone—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00519	CcSEcCtD
Progesterone—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000574	0.00517	CcSEcCtD
Progesterone—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000573	0.00516	CcSEcCtD
Progesterone—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000572	0.00515	CcSEcCtD
Progesterone—CYP17A1—medulla oblongata—amyotrophic lateral sclerosis	0.000559	0.0189	CbGeAlD
Progesterone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000551	0.00497	CcSEcCtD
Progesterone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000545	0.00491	CcSEcCtD
Progesterone—NR3C1—hindbrain—amyotrophic lateral sclerosis	0.000542	0.0183	CbGeAlD
Progesterone—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000541	0.00487	CcSEcCtD
Progesterone—SLC22A3—embryo—amyotrophic lateral sclerosis	0.000538	0.0182	CbGeAlD
Progesterone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00476	CcSEcCtD
Progesterone—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000527	0.00474	CcSEcCtD
Progesterone—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000526	0.00473	CcSEcCtD
Progesterone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000515	0.00464	CcSEcCtD
Progesterone—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000511	0.0046	CcSEcCtD
Progesterone—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00457	CcSEcCtD
Progesterone—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0005	0.0045	CcSEcCtD
Progesterone—Tension—Riluzole—amyotrophic lateral sclerosis	0.000498	0.00449	CcSEcCtD
Progesterone—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00444	CcSEcCtD
Progesterone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00442	CcSEcCtD
Progesterone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000488	0.0044	CcSEcCtD
Progesterone—SLC10A1—nervous system—amyotrophic lateral sclerosis	0.000482	0.0163	CbGeAlD
Progesterone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000476	0.00428	CcSEcCtD
Progesterone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000471	0.00424	CcSEcCtD
Progesterone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000469	0.00423	CcSEcCtD
Progesterone—SLC10A1—central nervous system—amyotrophic lateral sclerosis	0.000464	0.0157	CbGeAlD
Progesterone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000464	0.00418	CcSEcCtD
Progesterone—ESR1—embryo—amyotrophic lateral sclerosis	0.000459	0.0155	CbGeAlD
Progesterone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000458	0.00412	CcSEcCtD
Progesterone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000456	0.00411	CcSEcCtD
Progesterone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000455	0.0041	CcSEcCtD
Progesterone—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000449	0.00404	CcSEcCtD
Progesterone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000446	0.00402	CcSEcCtD
Progesterone—Cough—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00399	CcSEcCtD
Progesterone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00044	0.00396	CcSEcCtD
Progesterone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000438	0.00395	CcSEcCtD
Progesterone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000432	0.00389	CcSEcCtD
Progesterone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000432	0.00389	CcSEcCtD
Progesterone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000432	0.00389	CcSEcCtD
Progesterone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000431	0.00388	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000429	0.00387	CcSEcCtD
Progesterone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000427	0.00385	CcSEcCtD
Progesterone—OPRK1—nervous system—amyotrophic lateral sclerosis	0.000425	0.0144	CbGeAlD
Progesterone—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000423	0.00381	CcSEcCtD
Progesterone—ESR1—brainstem—amyotrophic lateral sclerosis	0.000421	0.0142	CbGeAlD
Progesterone—CYP17A1—nervous system—amyotrophic lateral sclerosis	0.00042	0.0142	CbGeAlD
Progesterone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000418	0.00376	CcSEcCtD
Progesterone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000414	0.00373	CcSEcCtD
Progesterone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000414	0.00373	CcSEcCtD
Progesterone—Infection—Riluzole—amyotrophic lateral sclerosis	0.000412	0.00371	CcSEcCtD
Progesterone—OPRK1—central nervous system—amyotrophic lateral sclerosis	0.000409	0.0138	CbGeAlD
Progesterone—Shock—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00367	CcSEcCtD
Progesterone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000406	0.00366	CcSEcCtD
Progesterone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000404	0.00364	CcSEcCtD
Progesterone—CYP17A1—central nervous system—amyotrophic lateral sclerosis	0.000404	0.0137	CbGeAlD
Progesterone—NR3C2—medulla oblongata—amyotrophic lateral sclerosis	0.000404	0.0136	CbGeAlD
Progesterone—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000403	0.0136	CbGeAlD
Progesterone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000402	0.00362	CcSEcCtD
Progesterone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000401	0.00361	CcSEcCtD
Progesterone—OPRK1—cerebellum—amyotrophic lateral sclerosis	0.0004	0.0135	CbGeAlD
Progesterone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000395	0.00356	CcSEcCtD
Progesterone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000387	0.00349	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000377	0.0034	CcSEcCtD
Progesterone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000375	0.00337	CcSEcCtD
Progesterone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000372	0.00335	CcSEcCtD
Progesterone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000369	0.00333	CcSEcCtD
Progesterone—SLC10A1—brain—amyotrophic lateral sclerosis	0.000368	0.0125	CbGeAlD
Progesterone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000368	0.00332	CcSEcCtD
Progesterone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000365	0.00328	CcSEcCtD
Progesterone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00036	0.00324	CcSEcCtD
Progesterone—NR3C2—spinal cord—amyotrophic lateral sclerosis	0.00036	0.0122	CbGeAlD
Progesterone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000358	0.00322	CcSEcCtD
Progesterone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000357	0.00322	CcSEcCtD
Progesterone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00319	CcSEcCtD
Progesterone—Pain—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00319	CcSEcCtD
Progesterone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000341	0.00307	CcSEcCtD
Progesterone—NR3C1—embryo—amyotrophic lateral sclerosis	0.000339	0.0115	CbGeAlD
Progesterone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00305	CcSEcCtD
Progesterone—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	0.000332	0.0112	CbGeAlD
Progesterone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00296	CcSEcCtD
Progesterone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000328	0.00295	CcSEcCtD
Progesterone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000328	0.00295	CcSEcCtD
Progesterone—OPRK1—brain—amyotrophic lateral sclerosis	0.000325	0.011	CbGeAlD
Progesterone—CYP17A1—brain—amyotrophic lateral sclerosis	0.000321	0.0108	CbGeAlD
Progesterone—NR3C1—brainstem—amyotrophic lateral sclerosis	0.000311	0.0105	CbGeAlD
Progesterone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000305	0.00275	CcSEcCtD
Progesterone—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000305	0.0103	CbGeAlD
Progesterone—NR3C2—nervous system—amyotrophic lateral sclerosis	0.000303	0.0103	CbGeAlD
Progesterone—SHBG—central nervous system—amyotrophic lateral sclerosis	0.000301	0.0102	CbGeAlD
Progesterone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000297	0.00268	CcSEcCtD
Progesterone—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	0.000296	0.01	CbGeAlD
Progesterone—SHBG—cerebellum—amyotrophic lateral sclerosis	0.000295	0.00996	CbGeAlD
Progesterone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000293	0.00264	CcSEcCtD
Progesterone—NR3C2—central nervous system—amyotrophic lateral sclerosis	0.000292	0.00987	CbGeAlD
Progesterone—NR3C2—cerebellum—amyotrophic lateral sclerosis	0.000285	0.00965	CbGeAlD
Progesterone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000283	0.00255	CcSEcCtD
Progesterone—PGR—nervous system—amyotrophic lateral sclerosis	0.000282	0.00953	CbGeAlD
Progesterone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000274	0.00247	CcSEcCtD
Progesterone—PGR—central nervous system—amyotrophic lateral sclerosis	0.000271	0.00918	CbGeAlD
Progesterone—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00027	0.00913	CbGeAlD
Progesterone—AR—spinal cord—amyotrophic lateral sclerosis	0.000267	0.00901	CbGeAlD
Progesterone—PGR—cerebellum—amyotrophic lateral sclerosis	0.000265	0.00897	CbGeAlD
Progesterone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000263	0.00237	CcSEcCtD
Progesterone—Rash—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00235	CcSEcCtD
Progesterone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00235	CcSEcCtD
Progesterone—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00026	0.00879	CbGeAlD
Progesterone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00026	0.00234	CcSEcCtD
Progesterone—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.000258	0.00873	CbGeAlD
Progesterone—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.000248	0.0084	CbGeAlD
Progesterone—CYP2A6—brain—amyotrophic lateral sclerosis	0.000247	0.00836	CbGeAlD
Progesterone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000246	0.00222	CcSEcCtD
Progesterone—SHBG—brain—amyotrophic lateral sclerosis	0.000239	0.00809	CbGeAlD
Progesterone—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.000237	0.00802	CbGeAlD
Progesterone—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	0.000235	0.00794	CbGeAlD
Progesterone—NR3C2—brain—amyotrophic lateral sclerosis	0.000232	0.00784	CbGeAlD
Progesterone—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000231	0.00781	CbGeAlD
Progesterone—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000228	0.00772	CbGeAlD
Progesterone—AR—nervous system—amyotrophic lateral sclerosis	0.000225	0.0076	CbGeAlD
Progesterone—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.000223	0.00755	CbGeAlD
Progesterone—ESR1—nervous system—amyotrophic lateral sclerosis	0.000221	0.00746	CbGeAlD
Progesterone—NR3C1—medulla oblongata—amyotrophic lateral sclerosis	0.000217	0.00732	CbGeAlD
Progesterone—AR—central nervous system—amyotrophic lateral sclerosis	0.000216	0.00731	CbGeAlD
Progesterone—PGR—brain—amyotrophic lateral sclerosis	0.000216	0.00729	CbGeAlD
Progesterone—ESR1—central nervous system—amyotrophic lateral sclerosis	0.000212	0.00718	CbGeAlD
Progesterone—ESR1—cerebellum—amyotrophic lateral sclerosis	0.000208	0.00702	CbGeAlD
Progesterone—SLC22A1—brain—amyotrophic lateral sclerosis	0.000206	0.00698	CbGeAlD
Progesterone—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000201	0.00679	CbGeAlD
Progesterone—SLC22A3—brain—amyotrophic lateral sclerosis	0.000197	0.00667	CbGeAlD
Progesterone—NR3C1—spinal cord—amyotrophic lateral sclerosis	0.000193	0.00653	CbGeAlD
Progesterone—SIGMAR1—brain—amyotrophic lateral sclerosis	0.000191	0.00645	CbGeAlD
Progesterone—ABCB1—embryo—amyotrophic lateral sclerosis	0.000181	0.00613	CbGeAlD
Progesterone—CYP1B1—brain—amyotrophic lateral sclerosis	0.000181	0.00613	CbGeAlD
Progesterone—AR—brain—amyotrophic lateral sclerosis	0.000172	0.00581	CbGeAlD
Progesterone—ESR1—brain—amyotrophic lateral sclerosis	0.000169	0.0057	CbGeAlD
Progesterone—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000168	0.00567	CbGeAlD
Progesterone—ABCC1—brain—amyotrophic lateral sclerosis	0.000163	0.00551	CbGeAlD
Progesterone—NR3C1—nervous system—amyotrophic lateral sclerosis	0.000163	0.0055	CbGeAlD
Progesterone—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000161	0.00546	CbGeAlD
Progesterone—NR3C1—central nervous system—amyotrophic lateral sclerosis	0.000157	0.0053	CbGeAlD
Progesterone—NR3C1—cerebellum—amyotrophic lateral sclerosis	0.000153	0.00518	CbGeAlD
Progesterone—CYP2C8—brain—amyotrophic lateral sclerosis	0.000139	0.0047	CbGeAlD
Progesterone—CYP1A1—brain—amyotrophic lateral sclerosis	0.000128	0.00433	CbGeAlD
Progesterone—NR3C1—brain—amyotrophic lateral sclerosis	0.000124	0.0042	CbGeAlD
Progesterone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000123	0.00416	CbGeAlD
Progesterone—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000121	0.00409	CbGeAlD
Progesterone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000118	0.00401	CbGeAlD
Progesterone—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000117	0.00394	CbGeAlD
Progesterone—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000116	0.00392	CbGeAlD
Progesterone—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000114	0.00385	CbGeAlD
Progesterone—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000103	0.0035	CbGeAlD
Progesterone—CYP2D6—brain—amyotrophic lateral sclerosis	9.26e-05	0.00313	CbGeAlD
Progesterone—ABCB1—nervous system—amyotrophic lateral sclerosis	8.71e-05	0.00295	CbGeAlD
Progesterone—ABCB1—central nervous system—amyotrophic lateral sclerosis	8.39e-05	0.00284	CbGeAlD
Progesterone—ABCB1—cerebellum—amyotrophic lateral sclerosis	8.2e-05	0.00277	CbGeAlD
Progesterone—ABCB1—brain—amyotrophic lateral sclerosis	6.66e-05	0.00225	CbGeAlD
Progesterone—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.96e-05	0.000415	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.95e-05	0.000414	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.95e-05	0.000414	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.95e-05	0.000414	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.95e-05	0.000412	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.94e-05	0.00041	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.92e-05	0.000406	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.91e-05	0.000404	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.9e-05	0.000403	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.89e-05	0.0004	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.87e-05	0.000396	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.87e-05	0.000395	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.84e-05	0.00039	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.84e-05	0.00039	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.83e-05	0.000387	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.83e-05	0.000387	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.83e-05	0.000387	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.82e-05	0.000386	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.82e-05	0.000386	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	1.81e-05	0.000383	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.81e-05	0.000383	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.81e-05	0.000383	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.8e-05	0.000381	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.79e-05	0.000379	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.79e-05	0.000378	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.77e-05	0.000375	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.77e-05	0.000374	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.77e-05	0.000374	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.73e-05	0.000367	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.73e-05	0.000367	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.73e-05	0.000366	CbGpPWpGaD
Progesterone—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	1.72e-05	0.000364	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.71e-05	0.000362	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.7e-05	0.000361	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.7e-05	0.00036	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.7e-05	0.00036	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.69e-05	0.000358	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.68e-05	0.000357	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.68e-05	0.000356	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.67e-05	0.000353	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.66e-05	0.000352	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	1.66e-05	0.000351	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.65e-05	0.000349	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.65e-05	0.000349	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.62e-05	0.000343	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.6e-05	0.000339	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.59e-05	0.000337	CbGpPWpGaD
Progesterone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.57e-05	0.000332	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.56e-05	0.000331	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.56e-05	0.000331	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.56e-05	0.000331	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.56e-05	0.00033	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.56e-05	0.00033	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.56e-05	0.000329	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.55e-05	0.000328	CbGpPWpGaD
Progesterone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.55e-05	0.000328	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.54e-05	0.000327	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.52e-05	0.000322	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.51e-05	0.000319	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.5e-05	0.000319	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.5e-05	0.000318	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	1.49e-05	0.000315	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.48e-05	0.000314	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.47e-05	0.000312	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.46e-05	0.00031	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.46e-05	0.000309	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.46e-05	0.000309	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.45e-05	0.000308	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.45e-05	0.000306	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000303	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.43e-05	0.000302	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.42e-05	0.0003	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.42e-05	0.0003	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.41e-05	0.000299	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.41e-05	0.000298	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	0.000296	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.39e-05	0.000295	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.38e-05	0.000293	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.37e-05	0.000289	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.36e-05	0.000289	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.34e-05	0.000284	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.34e-05	0.000284	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.33e-05	0.000282	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.33e-05	0.000281	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.32e-05	0.000279	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.31e-05	0.000277	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.3e-05	0.000274	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.28e-05	0.000271	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.27e-05	0.000269	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.26e-05	0.000268	CbGpPWpGaD
Progesterone—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	1.25e-05	0.000265	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.25e-05	0.000264	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.24e-05	0.000262	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.23e-05	0.00026	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.22e-05	0.000258	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.21e-05	0.000257	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.2e-05	0.000255	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.2e-05	0.000255	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.18e-05	0.000249	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000248	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.15e-05	0.000243	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.15e-05	0.000243	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.13e-05	0.00024	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.13e-05	0.000239	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.13e-05	0.000239	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	0.000238	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000237	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.1e-05	0.000233	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.1e-05	0.000233	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.1e-05	0.000232	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	0.000228	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.07e-05	0.000228	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.07e-05	0.000227	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.07e-05	0.000227	CbGpPWpGaD
Progesterone—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	1.07e-05	0.000226	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.07e-05	0.000226	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.05e-05	0.000222	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.03e-05	0.000219	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.03e-05	0.000218	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.02e-05	0.000217	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.02e-05	0.000215	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.01e-05	0.000214	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.01e-05	0.000214	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1e-05	0.000212	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	9.88e-06	0.000209	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	9.62e-06	0.000204	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	9.62e-06	0.000204	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.56e-06	0.000203	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.53e-06	0.000202	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	9.31e-06	0.000197	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	9.31e-06	0.000197	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.26e-06	0.000196	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	9.23e-06	0.000195	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—APOE—amyotrophic lateral sclerosis	9.22e-06	0.000195	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.21e-06	0.000195	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.16e-06	0.000194	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.98e-06	0.00019	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.87e-06	0.000188	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.86e-06	0.000188	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.81e-06	0.000186	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	8.7e-06	0.000184	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.54e-06	0.000181	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.49e-06	0.00018	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.45e-06	0.000179	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.42e-06	0.000178	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.4e-06	0.000178	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	8.31e-06	0.000176	CbGpPWpGaD
Progesterone—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	8.27e-06	0.000175	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.26e-06	0.000175	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.14e-06	0.000172	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.11e-06	0.000172	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.99e-06	0.000169	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.98e-06	0.000169	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	7.88e-06	0.000167	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.87e-06	0.000167	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.87e-06	0.000167	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	7.64e-06	0.000162	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.58e-06	0.000161	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	7.58e-06	0.00016	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.47e-06	0.000158	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.44e-06	0.000157	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.34e-06	0.000155	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.33e-06	0.000155	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.33e-06	0.000155	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.32e-06	0.000155	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.23e-06	0.000153	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.18e-06	0.000152	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.95e-06	0.000147	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	6.93e-06	0.000147	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.91e-06	0.000146	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.83e-06	0.000145	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.73e-06	0.000143	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.73e-06	0.000143	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	6.7e-06	0.000142	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.59e-06	0.00014	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.59e-06	0.00014	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.47e-06	0.000137	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.35e-06	0.000134	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.33e-06	0.000134	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.32e-06	0.000134	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.08e-06	0.000129	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	6.04e-06	0.000128	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	6.03e-06	0.000128	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.91e-06	0.000125	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.82e-06	0.000123	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.78e-06	0.000122	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.74e-06	0.000122	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	5.67e-06	0.00012	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.64e-06	0.00012	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.62e-06	0.000119	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.59e-06	0.000118	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	5.54e-06	0.000117	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.46e-06	0.000116	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.33e-06	0.000113	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.31e-06	0.000112	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.21e-06	0.00011	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.19e-06	0.00011	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.01e-06	0.000106	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	5e-06	0.000106	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5e-06	0.000106	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.79e-06	0.000101	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.75e-06	0.0001	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.74e-06	0.0001	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.6e-06	9.73e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.59e-06	9.72e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.47e-06	9.46e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.42e-06	9.36e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	4.37e-06	9.25e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.36e-06	9.23e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.3e-06	9.11e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.18e-06	8.85e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.14e-06	8.77e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.13e-06	8.75e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.13e-06	8.74e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.11e-06	8.7e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.1e-06	8.69e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.07e-06	8.62e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.05e-06	8.57e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.01e-06	8.48e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.85e-06	8.16e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.79e-06	8.03e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	3.78e-06	8.01e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.77e-06	7.99e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.75e-06	7.94e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.74e-06	7.92e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.62e-06	7.66e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.48e-06	7.37e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.38e-06	7.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.31e-06	7.01e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.3e-06	6.98e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.2e-06	6.77e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.13e-06	6.63e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.11e-06	6.58e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.08e-06	6.52e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.99e-06	6.34e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.83e-06	6e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.83e-06	5.99e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.81e-06	5.95e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.69e-06	5.69e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.63e-06	5.57e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.59e-06	5.49e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.47e-06	5.22e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.31e-06	4.9e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.26e-06	4.78e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.13e-06	4.51e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.12e-06	4.5e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.11e-06	4.47e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.03e-06	4.3e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.8e-06	3.82e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.39e-06	2.95e-05	CbGpPWpGaD
